Design and synthesis of triazolyl-napthyl derivative of ?-amyrin and its in vitro anti-cancer and apoptotic activities in human nasopharyngeal carcinoma (HK-1) cell line
DOI:
https://doi.org/10.3329/bjp.v11i1.24550Keywords:
Anti-cancer, Apoptotic, HK-1 cell line, Human nasopharyngeal carcinoma, Triazolyl-napthyl, ?-amyrinAbstract
The purpose of this research work was to design and synthesize triazolyl-napthyl derivative of ?-amyrin (TNB) using click chemistry approach. The cytotoxic activity of TNB was evaluated against HK-1 human nasopharyngeal carcinoma cells using MTT cell viability assay. Fluorescence microscopy indicated cellular morphological changes induced by TNB. Flow cytometry was involved to demonstrate the effect of this compound on cell cycle and apoptosis. The results revealed that TNB inhibited in vitro cancer cell growth in dose- and time-dependent manner. The IC50 values of TNB at 24 and 48 hours time intervals were found to be 47.2 and 32.5 µM respectively. TNB-treated cells exhibited significant dense staining fragmentation called apoptotic bodies, which inferred an early apoptotic event. DNA ladder was more apparent with the increasing the TNB dose. However, no DNA fragments were observed in the control groups. TNB also induced sub-G1 cell cycle arrest and increased fraction of HK-1 apoptotic cells.
Downloads
305
143 Read
215
Additional Files
- sound
- Scheme 1: Chemical synthesis of triazolyl-napthyl derivative of ?-amyrin using click chemistry approach
- Figure 1: Cytotoxic effect of triazolyl-napthyl derivative of ?-amyrin (TNB) in human nasopharyngeal carcinoma cells (HK-1)
- Figure 2: Effect of TNB on the nuclear morphology of HK-1 cancer cells using Hoechst 33258 staining at actual magnification 200x
- Figure 3: TNB induces DNA fragmentation in human nasopharyngeal cancer cells (HK-1)
- Figure 4: Effect of TNB on the cell cycle analysis of the HK-1 nasopharyngeal carcinoma cells
- Figure 5: Quantification of TNB-induced apoptosis in human nasopharyngeal cancer cells (HK-1)
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
